SCYX
Scynexis Inc

10,129
Mkt Cap
$27.28M
Volume
199,164.00
52W High
$1.49
52W Low
$0.565
PE Ratio
-1.21
SCYX Fundamentals
Price
$0.6477
Prev Close
$0.65
Open
$0.6416
50D MA
$0.697
Beta
1.10
Avg. Volume
653,798.05
EPS (Annual)
-$0.4388
P/B
0.75
Rev/Employee
$133,785.71
Loading...
Loading...
SCYNEXIS, Inc. is a biotechnology company, which engages in the development of novel oral and intravenous triterpenoid antifungal for the treatment of several fungal infections, including vulvovaginal candidiasis, invasive aspergillosis, invasive candidiasis, and refractory invasive fungal infections. The company was founded by Scot Kevin Huber, Terry Eugene Marquardt, Pierre Bernard Jacques Monnet, Russell J. Outcalt, and Yves Joseph Ribeill on November 4, 1999 and is headquartered in Jersey City, NJ.
Sector:
Health Technology
Industry:
Pharmaceuticals Major
Employees:
28

Frequently Asked Questions

What is Market Cap of Scynexis Inc?
What is the 52-week high for Scynexis Inc?
What is the 52-week low for Scynexis Inc?
What is Scynexis Inc stock price today?
What was Scynexis Inc stock price yesterday?
What is the PE ratio of Scynexis Inc?
What is the Price-to-Book ratio of Scynexis Inc?
What is the 50-day moving average of Scynexis Inc?
How many employess does Scynexis Inc has?

Latest SCYX News

View
No SCYX news at the moment.

Advertisement|Remove ads.

Advertisement|Remove ads.